FDA Inspection Trends Highlight Ongoing Quality System Weaknesses
Regulatory & Compliance FDA Inspection Trends Highlight Ongoing Quality System Weaknesses Recent comments from an FDA investigator shed light on the types of compliance issues most often identified during pharmaceutical manufacturing inspections. The discussion focused on trends seen in Form 483 observations and where companies continue to experience difficulties meeting GMP expectations. Quality Control Unit […]